Healthy people over 70 can safely take statins to lower their risk of heart attacks and strokes, according to a world-first clinical trial. The study, led by Australian researchers, is the first to show clear benefits in this age group without prior heart disease. For decades, doctors were unsure whether the drugs helped older adults who felt fine. Now, the evidence is in: statins work, and they are safe.
A decade of data, a clear answer
The trial followed more than 5,000 healthy Australians aged 70 and older for up to six years. Half took a daily statin, the other half a placebo. The results showed a significant drop in cardiovascular events among those on the drug. The risk of heart attack, stroke, or death from cardiovascular causes fell by about 20 percent. The researchers said the benefit appeared within the first year and grew over time.
Why this matters for older adults
Many older people are not prescribed statins because they have no history of heart problems. Doctors often weigh the potential side effects, like muscle pain, against unclear benefits. This trial gives them solid data to guide those decisions. The participants were generally healthy, not a high-risk group. So the findings apply to a large portion of the aging population. The researchers noted that the drug was well tolerated, with no increase in serious side effects.
A shift in preventive care
The study was conducted across multiple sites in Australia, with support from national health agencies. The lead researcher said the results should change clinical practice. Older patients, he argued, should not be excluded from preventive treatment just because of age. The trial offers a simple, low-cost way to reduce the burden of heart disease in a growing demographic. As populations age worldwide, such evidence becomes more urgent.
This is not a call for everyone over 70 to start taking statins. But it is a clear signal that age alone should not be a barrier. The next step is for health guidelines to catch up with the evidence. For now, older adults and their doctors have a new tool to consider in the fight against heart disease.
